Table: Rohto - 9-MTH group results

Rohto Pharmaceutical

12/02/2020 06:00

Feb 12 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              138.12              134.70           184.00    
                   (+2.5 pct)          (+8.5 pct)       (+0.2 pct)  
  Operating           18.13               17.19            21.50    
                   (+5.4 pct)          (+10.2 pct)      (+3.3 pct)  
  Recurring           18.07               17.62            21.30    
                   (+2.6 pct)          (+11.9 pct)      (+12.3 pct) 
  Net                 12.56               10.87            13.50    
                   (+15.6 pct)         (+7.6 pct)       (+37.8 pct) 
  EPS              110.17 yen           95.40 yen       118.35 yen  
  EPS Diluted      109.82 yen           95.03 yen                   
  Ann Div                               25.00 yen        26.00 yen  
  -Q2 div           13.00 yen           11.00 yen                   
  -Q4 div                               14.00 yen        13.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T